Mikael Bjorklund浙江大学爱丁堡大学联合学院 | 国际联合学院生物学· 细胞生长· 新陈代谢· 癌症· 线粒体个人简介:教育经历：1994.9-1998.7，库奥皮奥大学，硕士2000.9-2004.12，赫尔辛基大学，博士 研究和教学经历：1998-2000，库奥皮奥大学，助教 2000-2004，赫尔辛基大学，博士研究员2004-2007，赫尔辛基大学，博士后研究员2008-2009，赫尔辛基大学，芬兰科学院博士后研究员2010-2015，英国国家基金会Wellcome Trust研究员2009-2016，邓迪大学，PI学术会议（交流）:Key invited talks in International Conferences2016 EMBO Cell Size Regulation Joachimsthal Germany  2012 FASEB meeting AMPK and Beyond: Biology Disease Mechanisms and       Therapeutic Opportunities Asilomar Pacific Grove California2010 High Throughput Biology 2010 Karolinska Institutet Stockholm Sweden2006 HUGOs 11th annual Human Genome Meeting Helsinki Finland 教学与课程:未开课，栏目建设中研究与成果:主要研究方向和学术亮点及特色： 新陈代谢和细胞生长研究。 已有成果：Mikael Bjorklund博士共发表论文30篇，其中10篇重要论文为第一作者，12篇重要论文为通讯作者，发表在Nature、Cell、Developmental Cell、EMBO Journal等国际领先杂志上。Mikael Bjorklund博士领导多个国家项目（芬兰和英国），共取得科研基金约合1千5百万人民币。Selected recent publications:Miettinen TP Peltier J Härtlova A Gierliński M Jansen VM Trost M Björklund M. (2018) Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib. EMBO Journal 2018 37(10): e98359. Miettinen TP Björklund M. (2017) Mitochondrial Function and Cell Size: An Allometric Relationship. Trends in Cell Biology 27(6):393-402. Miettinen TP Björklund M. (2016) Cellular Allometry of Mitochondrial Functionality Establishes the Optimal Cell Size. Developmental Cell 39(3):370-382. Miettinen TP Björklund M. (2015) Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy. Cell Reports 13(11):2610-2620.             Original publications1. Miettinen TP Peltier J Hartlova A Gierliński M Jansen VM Trost M Björklund M. (2018) Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib. EMBO J. 37(10). pii: e98359 2. Sokolova M Turunen M Mortusewicz O Kivioja T Herr P Vaharautio A Björklund M Taipale M Helleday T Taipale J. (2017) Genome-wide screen of cell-cycle regulators in normal and tumor cells identifies a differential response to nucleosome depletion. Cell Cycle 16(2): 189–199. 3. Miettinen TP Björklund M. (2016) Cellular allometry of mitochondrial functionality establishes the optimal cell size. Developmental Cell 39(3):370-382 4. Miettinen TP Björklund M. (2015) Mevalonate pathway regulates cell size homeostasis and proteostasis through autophagy. Cell Reports 13(11):2610-20. 5. Miettinen TP Björklund M. (2015) Modified ribosome profiling reveals high abundance of ribosome protected mRNA fragments derived from 3 untranslated regions. Nucleic Acids Res 43(2):1019-34. 6. Miettinen TP Björklund M. (2014) NQO2 Is a Reactive Oxygen Species Generating Off-Target for Acetaminophen. Mol Pharm 11(12):4395-404.     7. Bischof J Sheils E Björklund M† Basler K†. (2014) Generation of a transgenic ORFeome library in Drosophila. Nature Protocols 9(7):1607-20. †co-corresponding authors 8. Miettinen TP Pessa H Caldez M Fuhrer T Diril M Sauer U Kaldis P Björklund M. (2014) Identification of Transcriptional and Metabolic Programs Related to Mammalian Cell Size. Current Biology 24(6):598-608. 9. Bischof J* Björklund M* Furger E Schertel C Taipale J Basler K. (2013) A versatile platform for creating a comprehensive UAS-ORFeome library in Drosophila. Development 140(11):2434-42. *equal contribution 10. Schertel C Huang D Björklund M Bischof J Yin D Li R Wu Y Zeng R Wu J Taipale J Song H Basler K. (2013) Systematic screening of a Drosophila ORF library in vivo uncovers Wnt/Wg pathway components. Developmental Cell 25(2):207-19.     11. Bonke M Turunen M Sokolova M Vähärautio A Kivioja T Taipale M Björklund M Taipale J. (2013) Transcriptional networks controlling the cell cycle. G3 (Bethesda) 3:75-90. ) 12. Alhopuro P* Björklund M* Sammalkorpi H Tuupanen S Biström M Niittymäki I Launonen V Saharinen J Nousiainen K Hautaniemi S Nuorva K Mecklin J Järvinen H Orntoft T Arango D Lehtonen R Karhu A Taipale J Aaltonen L. (2010) Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res 8:952-60. *equal contribution 13. Tuupanen S Turunen M Lehtonen R Hallikas O Vanharanta S Kivioja T Björklund M Wei G Yan J Niittymäki I Mecklin J Järvinen H Ristimäki A Di-Bernardo M East P Carvajal-Carmona L Houlston R.L Tomlinson I Palin K Ukkonen E Karhu A Taipale J Aaltonen L. (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nature Genetics 41:885-90.  14. Varjosalo M* Björklund M* Cheng F Syvanen H Kivioja T Kilpinen S Sun Z Kallioniemi O Stunnenberg HG He W-W Ojala P Taipale J. (2008) Application of active and kinase-deficient kinome collection for identification of kinases regulating Hedgehog signaling Cell 133 537–548. *equal contribution 15. Björklund M* Taipale M* Varjosalo M Saharinen J Lahdenperä J Taipale J. (2006) Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature 439 1009-1013. *equal contribution 16. Björklund M Aitio O Stefanidakis M Suojanen J Salo T Sorsa T Koivunen E. (2006) Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry 45 2862-2871.17. Björklund M Heikkila P Koivunen E. (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279 29589-29597.18. Björklund M Koivunen E. (2004) Steps towards phage display libraries with an extended amino acid repertoire. Letters in Drug Design&Discovery 1 163-7.             19. Stefanidakis M Björklund M Ihanus E Gahmberg CG Koivunen E. (2003) Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins. J Biol Chem 278 34674-34684.                  20. Björklund M Valtanen H Savilahti H Koivunen E. (2003) Use of intein-directed peptide biosynthesis to improve serum stability and bioactivity of a gelatinase inhibitory peptide. Comb Chem High Throughput Screen 6 29-35.      21. Ciftcioglu N Björklund M Kuorikoski K Bergstrom K Kajander EO. (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56 1893-1898.        Reviews and book chapters 22. Björklund M Marguerat S (2017). Editorial: Determinants of Cell Size. Front Cell Dev Biol. 2017 Dec 15;5:115.                        23. Miettinen TP Caldez MJ Kaldis P Björklund M. (2017) Cell size control – a mechanism for maintenance of fitness and function. BioEssays. DOI:10.1002/bies.201700058                       24. Miettinen TP Björklund M. (2017) Mitochondrial function and cell size: an  allometric relationship. Trends in Cell Biology 27(6):393-402. 25. Miettinen TP Björklund M. (2016) The mevalonate pathway as a metabolic requirement for autophagy–implications for growth control proteostasis and disease. Molecular & Cellular Oncology 3(3) e1143546.        26. Björklund M Stefanidakis M Ranta TM Kangasniemi A Ruohtula T and Koivunen E. (2009) Use of Phage Display to Discover Inhibitors of Cell Migration. In: Protein Discovery Technologies. Ed. R. Pasqualini and W. Arap CRC Press U.S.A p. 91-98. 27. Björklund M Koivunen E. (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755 37-69.  (The most downloaded review in BBA-Reviews on Cancer between April-June2005; http://top25.sciencedirect.com/index.php?subject_area_id=3&journal_id=0304419X&cat_id=4). Highly Cited Paper by Thomson Reuters Web of Science.     28. Kajander EO Björklund M Çiftçioglu N. (1999) Nanobacteria and man. In: Enigmatic Microorganisms and Life in Extreme Environments. Ed. J. Seckbach Kluwer Academic Publishers the Netherlands p. 195-204   科研:The main interest in my laboratory is how metabolism and cell size impact cellular fitness and functions and how these are linked to initiation and disease progression in cancers and other metabolic diseases. While our key focus is in how animal cells grow and regulate their size we are also using novel technologies such as thermal proteome profiling to understand function of small molecules related to cell growth.  所获专利:1. Bjorklund M Valtanen H and Koivunen E. Method for designing peptides. Patentapplication number: WO2004029245 US2006240510 2. Bjorklund M and Koivunen E. Peptide inhibitors of matrix metalloproteinaseactivity. Patent application number: US2007207967 3. Bjorklund  M and Koivunen E. Thioxothiazolidinone Compounds For Use As Pharmaceuticals. Patent application number: US2008108677